2020
DOI: 10.1111/and.13643
|View full text |Cite
|
Sign up to set email alerts
|

Anatomical endoscopic enucleation of the prostate: The next gold standard? Yes!

Abstract: Anatomical endoscopic enucleation of the prostate (AEEP) was first described by Haraoka (Haraoka, 1983). It was not until Fraundorfer and Gilling reported their initial experience with Holmium Laser Enucleation of the Prostate (HoLEP) in 1998 that the potential advantages of AEEP began to be appreciated (Fraundorfer & Gilling, 1998). AEEP differs from all other endoscopic procedures for benign prostatic obstruction (BPO) because it removes the entire benign prostatic hyperplasia (BPH) component of the prostate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 26 publications
0
13
0
Order By: Relevance
“…There are several possible reasons for these differences between HoLEP and TURP. Firstly, TURP cuts blood vessels during each resection process, which causing bleeding, while HoLEP cuts the tissue along the potential gap of the prostate capsule, avoiding the blood vessels in the prostatic tissue; meanwhile, holmium laser can coagulate blood vessels while cutting and produce a tissue coagulation layer of about 3 mm, producing better hemostasis performance (34)(35)(36). Secondly, the pulse wavelength of the Ho: YAG laser is 2,140 nm, and the pulse energy can be absorbed by water during the endoscopic operation with normal saline irrigation, which only produces a penetration depth of 0.4 mm and has good safety (6,37).…”
Section: Discussionmentioning
confidence: 99%
“…There are several possible reasons for these differences between HoLEP and TURP. Firstly, TURP cuts blood vessels during each resection process, which causing bleeding, while HoLEP cuts the tissue along the potential gap of the prostate capsule, avoiding the blood vessels in the prostatic tissue; meanwhile, holmium laser can coagulate blood vessels while cutting and produce a tissue coagulation layer of about 3 mm, producing better hemostasis performance (34)(35)(36). Secondly, the pulse wavelength of the Ho: YAG laser is 2,140 nm, and the pulse energy can be absorbed by water during the endoscopic operation with normal saline irrigation, which only produces a penetration depth of 0.4 mm and has good safety (6,37).…”
Section: Discussionmentioning
confidence: 99%
“…One of the most widely approved advantages of AEEP is its efficacy and safety in patients with large prostates [13]. A meta-analysis of three RCTs comparing HoLEP and SP reported similar enhancements in IPSS, QoL, Qmax, and PVR at both 12 and 24 months.…”
Section: Highly Safe and Effective For Males With Large Prostates And Independent Of Prostate Volumementioning
confidence: 97%
“…Level 1a demonstration recommends that AEEP furnishes at least equivalent, but possibly greater enhancements, in international prostate symptom score (IPSS), maximum urinary flow rates (Qmax), and post-void residual volumes (PVR) compared to those provided by vaporization and resection procedures [13].…”
Section: International Prostate Symptom Score Maximum Urinary Flow Rate Post-void Residual Volume and Quality Of Life: At Least Equivalenmentioning
confidence: 99%
See 1 more Smart Citation
“…Following the introduction from the historical and anatomical perspective (Reddy, Utley, & Gilling, 2020; Oh & Shitara, 2020), different techniques of AEEP by different energy source are illustrated (Ryang, Ly, Tran, Oh, & Cho, 2020; de Figueiredo, Cracco, de Marins, & Scoffone, 2020; Herrmann & Wolters, 2020; Rijo & Misrai, 2020). The surgical outcomes, with emphasis on postoperative continence and sexual functions, and complications of AEEP are summarised in the following chapters (Chen, Chung, Chu, Chen, & Ho, 2020; Lee, Cho, Juan, & Teoh, 2020; Cheng, Li, & Yu, 2020; Wei, Ke, Xu, & Xue, 2020) before a debate on AEEP as the next gold standard treatment for benign prostatic obstruction (Aho, Armitage, & Kastner, 2020; Wroclawski, Teles, & Carneiro, 2020). Finally, this Special Issue is rounded up by a discussion on surgical training (Teoh et al, 2020) and a survey on AEEP from urologists worldwide (Gudaru et al, 2020).…”
mentioning
confidence: 99%